Literature DB >> 14662710

Mechanism of ST elevation and ventricular arrhythmias in an experimental Brugada syndrome model.

Masaomi Kimura1, Takao Kobayashi, Shingen Owada, Keiichi Ashikaga, Takumi Higuma, Shingo Sasaki, Atsushi Iwasa, Shigeru Motomura, Ken Okumura.   

Abstract

BACKGROUND: Although phase 2 reentry is said to be responsible for initiation of ventricular tachycardia (VT) in Brugada syndrome, information about the activation sequence during VT is limited. METHODS AND
RESULTS: We developed an experimental Brugada syndrome model using a canine isolated right ventricular preparation cross-circulated with arterial blood of a supporter dog and examined the VT mechanism. Two plaque electrodes (35x30 mm) containing 96 bipolar electrodes were attached to the endocardium and epicardium. Saddleback and coved types of ST elevation in transmural ECG were induced by pilsicainide, a pure sodium channel blocker, and pinacidil, a KATP channel opener. Eighteen polymorphic VT episodes were recorded in 9 of the 12 preparations associated with ST elevation. Fourteen episodes spontaneously developed in 5 preparations after an extrasystole during basic drive pacing. Analysis of local recovery times revealed increased dispersion especially in epicardium, and the extrasystole originated from a site with a short recovery time, suggesting that phase 2 reentry was its mechanism. The other 4 VTs in 4 preparations were induced by premature stimulation. Analysis of the activation sequences during VT revealed reentry between epicardium and endocardium or reentry around an arc of a functional block confined to epicardium or endocardium with bystander activation of the other.
CONCLUSIONS: Electrical heterogeneity in the recovery phase was induced in this experimental Brugada syndrome model, which can be a substrate for the development of phase 2 reentry and the subsequent reentry around an arc of the functional block, resulting in sustained VT.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14662710     DOI: 10.1161/01.CIR.0000105762.94855.46

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  9 in total

1.  Dependence of phase-2 reentry and repolarization dispersion on epicardial and transmural ionic heterogeneity: a simulation study.

Authors:  Anat Maoz; David J Christini; Trine Krogh-Madsen
Journal:  Europace       Date:  2014-03       Impact factor: 5.214

2.  Diffuse fibrosis and repolarization disorders explain ventricular arrhythmias in Brugada syndrome: a computational study.

Authors:  Niccoló Biasi; Paolo Seghetti; Alessandro Tognetti
Journal:  Sci Rep       Date:  2022-05-20       Impact factor: 4.996

Review 3.  Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org).

Authors:  Pieter G Postema; Christian Wolpert; Ahmad S Amin; Vincent Probst; Martin Borggrefe; Dan M Roden; Silvia G Priori; Hanno L Tan; Masayasu Hiraoka; Josep Brugada; Arthur A M Wilde
Journal:  Heart Rhythm       Date:  2009-07-08       Impact factor: 6.343

4.  Mapping of reentrant spontaneous polymorphic ventricular tachycardia in a Scn5a+/- mouse model.

Authors:  Claire A Martin; Laila Guzadhur; Andrew A Grace; Ming Lei; Christopher L-H Huang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-03-04       Impact factor: 4.733

Review 5.  Brugada syndrome.

Authors:  Carlo Napolitano; Silvia G Priori
Journal:  Orphanet J Rare Dis       Date:  2006-09-14       Impact factor: 4.123

Review 6.  Experimental Models of Brugada syndrome.

Authors:  Franziska Sendfeld; Elisabet Selga; Fabiana S Scornik; Guillermo J Pérez; Nicholas L Mills; Ramon Brugada
Journal:  Int J Mol Sci       Date:  2019-04-29       Impact factor: 5.923

7.  Basis for the Induction of Tissue-Level Phase-2 Reentry as a Repolarization Disorder in the Brugada Syndrome.

Authors:  Alfonso Bueno-Orovio; Elizabeth M Cherry; Steven J Evans; Flavio H Fenton
Journal:  Biomed Res Int       Date:  2015-10-25       Impact factor: 3.411

8.  Specific decreasing of Na+ channel expression on the lateral membrane of cardiomyocytes causes fatal arrhythmias in Brugada syndrome.

Authors:  Kunichika Tsumoto; Takashi Ashihara; Narumi Naito; Takao Shimamoto; Akira Amano; Yasutaka Kurata; Yoshihisa Kurachi
Journal:  Sci Rep       Date:  2020-11-17       Impact factor: 4.379

Review 9.  Brugada Syndrome: Different Experimental Models and the Role of Human Cardiomyocytes From Induced Pluripotent Stem Cells.

Authors:  Yingrui Li; Siegfried Lang; Ibrahim Akin; Xiaobo Zhou; Ibrahim El-Battrawy
Journal:  J Am Heart Assoc       Date:  2022-03-24       Impact factor: 6.106

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.